Bizarre Patents
Mouse device with a built-in printer
A mouse device for use as an input device of a computer is provided that includes a housing in which recording paper is loadable, and a printer unit provided within the housing for printing on the recording paper print information received from the computer.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6846905 | Antigen constructs useful in the detection and differentiation of antibodies to HIV Isolated HIV-1 Group O env polypeptides obtained from the HIV-1 isolate HAM112 are claimed, as well as (a) antigen constructs comprising fusions of one or more of each of HIV-1 Group O env polypeptides and HIV-1 Group M env polypeptide and (b) further antigen constr... | 01/25/2005 |
| 6797479 | Reagents and methods for the detection and quantification of vancomycin in biological fluids Immunoassay reagents, methods and test kits for the specific quantification of vancomycin in a test sample are disclosed. The reagent comprises antibodies prepared with immunogens of FIG. 6 wherein P is an immunogenic carrier material and X is a linking moiet... | 09/28/2004 |
| 6767708 | Stabilized aqueous steroid immunoassay standards Aqueous solutions of steroid compounds which have biological activity and have a tendency to oxidative degradation at temperatures between 2 and 8° C. on storage in excess of several months are stabilized by the addition of chelators. Aqueous solutions of particula... | 07/27/2004 |
| 6686170 | Assay devices with mobile control reagents The present invention relates to an improved immunoassay device for confirming the validity of a test result showing either the presence or absence of an analyte in a patient sample. In the improved device, control reagents are provided in the device whic... | 02/03/2004 |
| 6673629 | Neutralization of polycations in a chromatographic device for whole blood use A chromatography assay device and method for use with whole blood samples utilizing a red blood cell separating agent to aggregate red blood cells and permit plasma or serum to flow by capillary action and a neutralizing agent to neutralize any effects th... | 01/06/2004 |
| 6605476 | Immunochromatographic assay device A chromatography immunoassay device is described which can be used more easily, is protected from moisture and/or oxygen more effectively and can be produced at a lower cost than known chromatography immunoassay devices. The chromatography immunoassay dev... | 08/12/2003 |
| 6534320 | Process for immunochromatography with colloidal particles The present invention relates to improved specific binding assay methods, kits and devices utilizing chromatographically mobile specific binding reagents labelled with colloidal particles. Specific binding reagents labelled with colloidal particles such a... | 03/18/2003 |
| 6472227 | Barbiturate assay, tracers, immunogens, antibodies and kit The present invention is directed to a fluorescence polarization immunoassay for barbiturates, to the various components needed for preparing and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and ... | 10/29/2002 |
| 6316265 | Determination of % glycated hemoglobin A glycated hemoglobin assay utilizes a simple procedure for the determination of standardized %GHb in whole blood samples correlated to the Diabetes Control and Complications Trial (DCCT). First, a lysed whole blood sample is incubated with a solid phase ... | 11/13/2001 |
| 6211395 | Enantioselective synthesis of 3-aminopyrrolidines The invention relates to a process of preparing a chiral compound of the formula: ##STR1## wherein R1 is selected from the group consisting of hydrogen and lower alkyl, and R2 and R2' are the same, and R2 and R | 04/03/2001 |
| 6197974 | Enantioselective synthesis of 3-aminopyrrolidines The invention relates to a process of preparing a chiral compound of the formula: ##STR1## wherein R1 is selected from the group consisting of hydrogen and lower alkyl, and R2 and R2' are the same, and R2 and R | 03/06/2001 |
| 6193954 | Formulations for pulmonary delivery of dopamine agonists The present invention relates to methods and formulations for administering a dopamine agonist to the airways of a patient. The preferred dopamine agonist is selected from (5aR-trans)-4,5,6,7,11b-hexahydro-2-propylbenzo[f]thieno[2,3-c]quinoline- 9,10... | 02/27/2001 |
| 6162645 | Determination of % glycated hemoglobin A glycated hemoglobin assay utilizes a simple procedure for the determination of standardized %GHb in whole blood samples correlated to the Diabetes Control and Complications Trial (DCCT). First, a lysed whole blood sample is incubated with a solid phase ... | 12/19/2000 |
| 6160153 | Phosphatase activated crosslinking conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating The present invention provides crosslinking, conjugating and reducing agents which are functional with at least one phosphorothioate monoester group (--SPO3--2). Crosslinking and conjugation methods as well as solid phase reagents an... | 12/12/2000 |
| 6159750 | Fluorescence polarization immunoassay diagnostic method A method for fluorescence polarization immunoassay (FPIA) involves adding to a fluid container one or more reagents and a sample whose analyte is to be detected and measured, and then taking a first polarization measurement of the sample. More reagent is ... | 12/12/2000 |
| 6139781 | Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes Chemiluminescent electron-rich aryl-substituted 1,2-dioxetane compounds are disclosed in which the aryl group is poly-substituted with suitable electron-donating groups such that the light-emitting pattern of the molecule results in a very high luminescen... | 10/31/2000 |
| 6057429 | Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents The present invention provides crosslinking, conjugating and reducing agents which are functional with at least one phosphorothioate monoester group (--SPO3-2). Crosslinking and conjugation methods as well as solid phase reagents and... | 05/02/2000 |
